India's indigenous tetravalent dengue vaccine, DengiAll, has been developed by Panacea Biotec and the first participant in this trial was vaccinated on Wednesday at the Pandit Bhagwat Dayal Sharma ...

As transmission patterns shift and vulnerability deepens, tackling dengue’s structural inequities can involve collaborative, ...

India's one-shot dengue vaccine 'DengiAll' reaches 70% enrolment in Phase III trials across 20 national sites.

A dengue outbreak in Gadchiroli, Maharashtra, has resulted in one confirmed death and three suspected fatalities, leading to ...

Dengue remains a major public health challenge in India. Data from the Integrated Health Information Platform (IHIP) indicates that there were 573,563 laboratory-confirmed dengue cases reported in ...

Indian Immunologicals Limited (IIL), a prominent vaccine manufacturer, is on track to launch its dengue fever vaccine for commercial use by early 2026, according to a senior executive.

COMBAT employs brain organoids, miniature, lab-grown human brain-like tissues, to investigate how dengue invades the nervous ...

MUMBAI: In a first of its kind joint initiative in the field of medical research, the European Union (EU) and India have come ...

A multi-institutional study on dengue led by researchers at the Indian Institute of Science (IISc) shows how the virus causing the disease has evolved dramatically over the last few decades in the ...

ICMR says that the trial participants were selected from different zones across India to ensure the vaccine’s efficacy ...

Dengue, a mosquito-borne disease, has over the last few years become a major public health concern in India, with 31,464 dengue cases and 36 related deaths reported between January and July 31, 2023.

Bangladesh is facing a critical dengue outbreak with 101 deaths and over 24,000 infections reported this year. Experts warn ...